As of 2025-11-13, the Intrinsic Value of Sensei Biotherapeutics Inc (SNSE) is -106.44 USD. This SNSE valuation is based on the model Peter Lynch Fair Value. With the current market price of 10.10 USD, the upside of Sensei Biotherapeutics Inc is -1,153.87%.
Based on its market price of 10.10 USD and our intrinsic valuation, Sensei Biotherapeutics Inc (SNSE) is overvalued by 1,153.87%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -106.44 - -106.44 | -106.44 | -1,153.87% |
| P/E | (272.49) - (378.93) | (338.48) | -3451.3% |
| DDM - Stable | (172.53) - (735.74) | (454.13) | -4596.4% |
| DDM - Multi | (175.94) - (604.72) | (275.09) | -2823.6% |
| Market Cap (mil) | 12.73 |
| Beta | 1.85 |
| Outstanding shares (mil) | 1.26 |
| Enterprise Value (mil) | 0.51 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.62% |
| Cost of Debt | 5.00% |
| WACC | 9.22% |